Related Experiment Video
Updated: Jul 8, 2026

10:10
A Model of Free Tissue Transfer: The Rat Epigastric Free Flap
Published on: January 15, 2017
16.9K
Head and Neck Free-Flap Reconstruction in Patients With Pre-Existing Coagulopathies: A Case Series
Grace Anne Longfellow1, Makayla Matthews1, Gabrielle Adams1
1School of Medicine, University of North Carolina at Chapel Hill, NC, USA.
Ear, Nose, & Throat Journal
|July 13, 2025
Summary
Patients with inherited coagulopathies undergoing microvascular reconstruction have high thrombotic risks. Individualized anticoagulation is crucial to prevent complications like flap loss, as optimal perioperative strategies are still undefined.
Area of Science:
- Plastic Surgery
- Hematology
- Vascular Surgery
Background:
- Patients with inherited coagulopathies, including thrombophilias, face increased thrombotic risks during microvascular reconstruction.
- Optimal perioperative management strategies for these patients remain undefined.
Purpose of the Study:
- To evaluate perioperative outcomes in patients with inherited coagulopathies undergoing head and neck free flap reconstruction.
- To assess the impact of anticoagulation strategies on thrombotic complications.
Main Methods:
- Retrospective case series of 15 patients with confirmed inherited coagulopathies undergoing head and neck free flap reconstruction.
- Analysis of preoperative, intraoperative, and postoperative anticoagulation regimens.
- Evaluation of flap outcomes, thrombotic events, and bleeding complications.
Main Results:
- The most common coagulopathies were sickle cell trait (40.0%) and Factor V Leiden (26.7%).
- Two patients (13.3%) experienced flap loss due to thrombosis; neither received intraoperative anticoagulation.
- No major bleeding events occurred; 40.0% required postoperative transfusions.
Conclusions:
- Targeted screening, multidisciplinary coordination, and individualized anticoagulation are essential to mitigate thrombotic complications.
- Further prospective studies are needed to develop standardized perioperative protocols for this high-risk population.
Related Concept Videos
Stem Cell Therapy for Tissue Regeneration
Stem cell therapy is a method used in regenerative medicine to repair and restore function to damaged tissues and organs. Stem cells have the potential to proliferate and differentiate into various tissue types, making them ideal candidates for tissue regeneration. For example, hematopoietic stem cell transplants are commonly used in blood cancer treatment to replenish damaged bone marrow and restore healthy blood cells.
Types of Stem Cells used in Stem Cell Therapy
The two main cell types that...
Types of Stem Cells used in Stem Cell Therapy
The two main cell types that...
Bone Marrow Sampling and Transplants
Bone marrow transplant is a potential cure for several diseases, including cancer and specific genetic disorders. Notably, this procedure is applicable for patients suffering from aplastic anemia, certain types of leukemia, severe combined immunodeficiency disease (SCID), Hodgkin's disease, non-Hodgkin's lymphoma, multiple myeloma, thalassemia, sickle-cell disease, and certain cancers.
The transplant begins with high doses of chemotherapy and radiation treatment, which aim to destroy the...
The transplant begins with high doses of chemotherapy and radiation treatment, which aim to destroy the...
Tissue Transplantation
Tissue transplantation is a significant medical procedure involving the transfer of cells, tissues, or organs from a donor to a recipient, with the primary aim of restoring lost functions. This procedure is crucial in treating a broad spectrum of diseases, including kidney diseases, liver failure, heart disease, and certain types of cancers.
The Biology of Tissue Transplantation
The biology of tissue transplantation hinges on the Major Histocompatibility Complex (MHC) molecules. These molecules...
The Biology of Tissue Transplantation
The biology of tissue transplantation hinges on the Major Histocompatibility Complex (MHC) molecules. These molecules...

